As patent cliff looms, collaborations for mAB biosimilars are born

01.10.11 Budapest/Bad Vilbel – Hungarian drug maker Gedeon Richter plc and German STADA Arzneimittel AG have signed two separate licensing and marketing contracts to develop biosimilar versions of the monoclonal antibody drugs Rituximab... more

Solvo signs deal

09.08.11 Budapest/Macclesfield – UK-headquartered global ADME-Tox specialist Cyprotex plc has partnered up with Solvo Bio­tech sro to provide the Hungarian firm’s drug transporter assays to its customers in the bio­pharmaceutical... more

GMO crops ploughed under

09.08.11 Budapest/Kraków – In July, illegally planted genetically modified crops made headlines in Hungary, where GMO acreage is banned. Up to 0.1% GMO maize products from Monsanto and Pioneer were discovered at four sites (near... more

Big backing

04.04.11 Budapest – Hungarian vaccine developer Genetic Immunity Kft. (GI) has secured a cash injection of US$25m by signing an agreement with the Budapest-based technology commercialisation company Power of the Dream Ventures, Inc. The... more

Biosimilar deal as patents expire

06.02.11 Budapest/Tokyo – Hungary’s largest drugmaker Gedeon Richter Nyrt. has secured access to the Japanese market for its biosimilar pipeline. In mid-December, Richter CEO Erik Bogsch announced his company had signed a long-term... more